Lenfant Francois, Lahet Jean-Jacques, Chaillot Bernard, Freysz Marc
Département d'Anésthesie Réanimation, CHU de Dijon, Hôpital Général, 3 rue du Faubourg Raines, 21033 Dijon, France.
Cell Mol Biol Lett. 2004;9(2):301-4.
Erythrocyte storage may result in cell damage due to an alteration of membrane integrity, which results in potassium efflux and hemolysis. Lidocaine has been shown to protect erythrocytes from oxidative stress by a possible membrane effect. We conducted this study to examine the effects of lidocaine on human erythrocyte storage. Erythrocytes were kept for seven days at 04 degrees C in the absence or in presence of plasma, and of lidocaine at 36.9 and 221.6 microM. Cell damage was assessed by measuring potassium efflux in the supernatant after seven days, and studying potassium efflux and hemolysis induced by oxidative stress. As expected, erythrocyte storage in the presence of plasma was less deleterious. Lidocaine decreased potassium efflux after 7 days' storage. Resistance toward oxidative stress was greater when the erythrocytes had been kept in the presence of plasma. Considering that lidocaine is widely used in various clinical situations, this data may be of clinical relevance.
红细胞储存可能会因膜完整性改变导致细胞损伤,进而引起钾离子外流和溶血。利多卡因已被证明可通过可能的膜效应保护红细胞免受氧化应激。我们进行这项研究以检验利多卡因对人红细胞储存的影响。红细胞在有无血浆以及含有36.9微摩尔/升和221.6微摩尔/升利多卡因的情况下于4℃保存7天。通过测量7天后上清液中的钾离子外流,并研究氧化应激诱导的钾离子外流和溶血来评估细胞损伤。正如预期的那样,在有血浆存在的情况下进行红细胞储存危害较小。利多卡因可减少储存7天后的钾离子外流。当红细胞在有血浆存在的情况下保存时,对氧化应激的抵抗力更强。鉴于利多卡因在各种临床情况下广泛使用,这些数据可能具有临床相关性。